The aim of this trial is to evaluate the differences in pain relief, neurological function, quality of life and survival in patients with metastatic epidural spinal cord compression (MESCC) who are managed with a combination of surgery and radiotherapy versus radiotherapy alone. Further we shall evaluate cost-effectiveness of the two treatment approaches.
Study Type
OBSERVATIONAL
Enrollment
163
Surgical excision of the metastatic process
Standard of care radiotherapy for patients with metastatic epidural spinal cord compression.
University of Kansas Medical Center
Kansas City, Kansas, United States
Johns Hopkins University
Baltimore, Maryland, United States
Mayo Clinic
Rochester, Minnesota, United States
Change in spine-associated pain intensity (BPI) measured by Brief Pain Inventory
Time frame: 6 weeks / 3, 6, 9, 12, 18, 24 months
Neurological outcomes measured by American Spinal Injury Association (ASIA) Motor Scale structured clinical examination
Time frame: 24 months
Survival
Time frame: 24 months
SF-36 v2
Time frame: 24 month
EQ-5D
Time frame: 24 months
Oswestry Disability Index (ODI)
Time frame: 24 months
Caregiver Activity Survey
Time frame: 24 months
Adverse events
Time frame: 24 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Thomas Jefferson University and The Rothman Institute
Philadelphia, Pennsylvania, United States
University of Texas Hospital / MD Anderson Cancer Center
Houston, Texas, United States
West Viginia University
Morgantown, West Virginia, United States
University of British Columbia
Vancouver, British Columbia, Canada
Sunnybrook Health Sciences Center
Toronto, Ontario, Canada
University of Toronto
Toronto, Ontario, Canada